Juan Carlos Conde, nuevo Director General de Teva para España y Portugal
PMFarma utiliza cookies propias y de terceros para recopilar informacion con la finalidad de mejorar nuestros servicios y mostrarte publicidad relacionada con tus preferencias. Al continuar navegando por el sitio, aceptas el uso de las mismas. Tienes la posibilidad de configurar tu navegador pudiendo impedir que sean instaladas. Configurar | Aceptar Toggle navigation
Juan Carlos Conde, nuevo Director General de Teva para España y Portugal
Con más de 17 años de experiencia en la compañía farmacéutica, Juan Carlos Conde sustituirá en el cargo a Carlos Teixeira.
Juan Carlos Conde, nuevo director general de TEVA para España y Portugal
infosalus.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from infosalus.com Daily Mail and Mail on Sunday newspapers.
The European recovery: How pharma can drive sustainable post-pandemic growth
epmmagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from epmmagazine.com Daily Mail and Mail on Sunday newspapers.
Operator
Ladies and gentlemen, thank you for standing by. Welcome to today s Teva fourth-quarter and full-year 2020 financial results. [Operator instructions] I must advise you that this conference is being recorded today, Wednesday, the 10th of February 2021. I would now like to hand the conference over to your speaker today, Kevin Mannix, senior vice president, head of investor relations.
Please go ahead, sir.
Senior Vice President, Head of Investor Relations
Thank you, Sharon. And thank you, everyone, for joining us today to discuss Teva s fourth-quarter and full-year 2020 financial results. We hope you ve had an opportunity to review our press release, which was issued one hour ago. A copy of the release, as well as a copy of the slides being presented on this call can be found on our website at www.tevapharm.com.